Abstract
Peptide mimetic compounds 9d and 9h showed good selectivity for FVIIa/TF over other serine proteases. Xray crystal structure analysis revealed that a large moiety at P3 interacted in a novel manner with the 170-loop and was accompanied by ligand-induced conformational change of the 170-loop. From additional optimization, we discovered compound 10b, an excellent extrinsic pathway-selective inhibitor.
Keywords: Structure-based drug design, Serine protease, FVIIa inhibitor, 2 x APTT/2 x PT ratio, X-ray crystal structure, Ligand-induced conformational change
Letters in Drug Design & Discovery
Title: Structure-Based Drug Design of Peptide Mimetics Containing Large P3 Moieties as Inhibitors of Factor VIIa
Volume: 6 Issue: 2
Author(s): Kunihiro Hattori, Toshiro Kozono, Haruhiko Sato, Masateru Ohta, Keiko Esaki, Takehisa Kitazawa, Kazutaka Yoshihashi, Akihisa Sakamoto, Yoshiaki Watanabe, Takuya Shiraishi, Takaki Koga, Tohru Esaki, Hitoshi Iikura, Yoshiyuki Ono, Hirofumi Kodama, Masayuki Haramura and Shojiro Kadono
Affiliation:
Keywords: Structure-based drug design, Serine protease, FVIIa inhibitor, 2 x APTT/2 x PT ratio, X-ray crystal structure, Ligand-induced conformational change
Abstract: Peptide mimetic compounds 9d and 9h showed good selectivity for FVIIa/TF over other serine proteases. Xray crystal structure analysis revealed that a large moiety at P3 interacted in a novel manner with the 170-loop and was accompanied by ligand-induced conformational change of the 170-loop. From additional optimization, we discovered compound 10b, an excellent extrinsic pathway-selective inhibitor.
Export Options
About this article
Cite this article as:
Hattori Kunihiro, Kozono Toshiro, Sato Haruhiko, Ohta Masateru, Esaki Keiko, Kitazawa Takehisa, Yoshihashi Kazutaka, Sakamoto Akihisa, Watanabe Yoshiaki, Shiraishi Takuya, Koga Takaki, Esaki Tohru, Iikura Hitoshi, Ono Yoshiyuki, Kodama Hirofumi, Haramura Masayuki and Kadono Shojiro, Structure-Based Drug Design of Peptide Mimetics Containing Large P3 Moieties as Inhibitors of Factor VIIa, Letters in Drug Design & Discovery 2009; 6 (2) . https://dx.doi.org/10.2174/157018009787582606
DOI https://dx.doi.org/10.2174/157018009787582606 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ventricular Arrhythmias in Patients with Obstructive Sleep Apnea
Current Cardiology Reviews ATP-Sensitive Potassium Channel Openers and 2,3-Dimethyl-2-Butylamine Derivatives
Current Medicinal Chemistry Shear Stress-sensitive Carriers for Localized Drug Delivery
Current Pharmaceutical Design A Comprehensive Review on Exosomes and Microvesicles as Epigenetic Factors
Current Stem Cell Research & Therapy Insulin Secretagogues, Sulfonylurea Receptors and KATP Channels
Current Pharmaceutical Design Regulation of Cellular Transport by Klotho Protein
Current Protein & Peptide Science Editorial (Thematic Issue: Current Update on Association Between Alzheimer’s Disease and Type 2 Diabetes: Volume I)
CNS & Neurological Disorders - Drug Targets Vascular Risk Factors, Vascular Diseases, and Imaging Findings in a Hospital-based Cohort of Mild Cognitive Impairment Types
Current Alzheimer Research Editorial: Review on Intracerebral Haemorrhage: Multidisciplinary Approaches to the Injury Mechanism Analysis and Therapeutic Strategies
Current Pharmaceutical Design Anti-cancer Scopes and Associated Mechanisms of Scutellaria Extract and Flavonoid Wogonin
Current Cancer Therapy Reviews Patent Selections:
Recent Patents on Cardiovascular Drug Discovery Non-Traditional Cardiovascular Risk Markers in the Era of Established Major Risk Factors and Multiple Guidelines
Current Vascular Pharmacology Aldehyde Dehydrogenase-2 Roles in Ischemic Cardiovascular Disease
Current Drug Targets Monitoring of the Antiplatelet Drugs Effect in Patients with Coronary Artery Disease: What is the Real Clinical Impact?
Current Vascular Pharmacology Discovery of Neurogenic, Alzheimers Disease Therapeutics
Current Alzheimer Research Targeting Tumor Microenvironment with Silibinin: Promise and Potential for a Translational Cancer Chemopreventive Strategy
Current Cancer Drug Targets The Role of COX-2 in Acute Pain and the Use of Selective COX-2 Inhibitors for Acute Pain Relief
Current Pharmaceutical Design Sigma Receptor Activation Reduces Infarct Size at 24 Hours After Permanent Middle Cerebral Artery Occlusion in Rats
Current Neurovascular Research PLACD-7T Study: Atherosclerotic Carotid Plaque Components Correlated with Cerebral Damage at 7 Tesla Magnetic Resonance Imaging
Current Cardiology Reviews Modulation of Eating by Central Catecholamine Systems
Current Drug Targets